Noa Therapeutics is a preclinical biotech firm that is leading the way in the development of multimodal treatments.
Noa Therapeutics has raised $367K in total funding. The most recent round was Grant. The last funding was announced in July 2024.
Noa Therapeutics's investors include Business Development Bank of Canada, Ontario Centre of Innovation, UCeed, Archangel Network of Funds, NorthSpring Capital Partners.
Noa Therapeutics is headquartered in Toronto, Canada.
Noa Therapeutics is a preclinical biotech firm that is leading the way in the development of multimodal treatments.
Noa Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Noa Therapeutics — Funding & Investors." VCBacked, July 8, 2024, https://www.vcbacked.co/company/noa-therapeutics. Accessed August 13, 2026.
VCBacked. (2024). Noa Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/noa-therapeutics
{{cite web |title=Noa Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/noa-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated